Guodong Sun

Guodong Sun

Auto-generated profile, based on publicly available information

Guodong Sun

Department of Medical Affairs, Lanzhou University First Hospital , Lanzhou 730000

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in World Journal of Gastroenterology
Verified
Journal Article
Open access
NSNi Shi
Ni Shi
GSGuo-Dong Sun
Guo-Dong Sun
YJYuanyuan Ji
Yuanyuan Ji
Ying WangYing Wang
Ying Wang
YZYu-Cheng Zhu
Yu-Cheng Zhu
YGYang Gao
Yang Gao
Effects of acute kidney injury on acute pancreatitis patients’ survival rate in intensive care unit: A retrospective study

1 January 2025 in Therapeutic Advances in Medical Oncology
Verified
Journal Article
Open access
HCHuijuan Cheng
Huijuan Cheng
HGHongkai Guo
Hongkai Guo
CWChengming Wen
Chengming Wen
GSGuodong Sun
Guodong Sun
FTFutian Tang
Futian Tang
YLYumin Li
Yumin Li
Pancreatic cancer ranks among the most lethal digestive malignancies, exhibiting a steadily increasing incidence and mortality worldwide. Despite significant advances in cancer research, the 5-year survival rate remains below 10%, predominantly due to delayed diagnosis and limited therapeutic options. Concurrently, the gut microbiota—an integral component of host physiology—has emerged as a crucial player in the pathogenesis of pancreatic cancer. Mounting evidence indicates that alterations in gut microbial composition and function may influence tumor initiation, progression, and response to therapy. This review provides an in-depth examination of the intricate interplay between the gut microbiome and pancreatic cancer, highlighting potential diagnostic biomarkers and exploring microbiome-targeted therapeutic strategies to improve patient outcomes.

29 January 2026 in Discover Oncology
Verified
Journal Article
Open access
PDF file
GSGuodong Sun
Guodong Sun
HCHuijuan Cheng
Huijuan Cheng
MYMinhong Yin
Minhong Yin
Oral hygiene, traditionally regarded as a pillar of dental care, is increasingly recognized for its broader relevance to systemic health, including cancer prevention. Accumulating evidence suggests that poor oral hygiene may contribute to carcinogenesis through pathways involving chronic inflammation, microbial dysbiosis, and immune dysregulation. This review synthesizes epidemiological studies linking indicators of poor oral health—such as periodontal disease and tooth loss—to elevated risks of head and neck, gastrointestinal, and other cancers. It also explores biological mechanisms that plausibly connect the oral environment to systemic oncogenesis. Integrating oral health promotion into lifestyle medicine frameworks and national public health strategies presents an opportunity for low-cost, scalable interventions to mitigate cancer burden, particularly in underserved populations. Future priorities include longitudinal research to strengthen causal inference, biomarker discovery for early detection, and policy initiatives embedding oral health within comprehensive disease prevention models. Recognizing oral hygiene as an integral component of systemic health may foster more holistic and equitable approaches to cancer prevention worldwide.

26 September 2026 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MYMinhong Yin
Minhong Yin
GSGuodong Sun
Guodong Sun
RHRonghua Huang
Ronghua Huang
HCHuijuan Cheng
Huijuan Cheng
Objectives: BRICS countries carry a substantial infectious-disease burden, but evidence spanning the pandemic and early post-pandemic period remains limited. Methods: Data were obtained from the Global Burden of Disease 2023 Results Tool. Infectious diseases were classified into five categories: HIV/AIDS and sexually transmitted infections (HIV/STIs); respiratory infections and tuberculosis (RITB); enteric infections; neglected tropical diseases and malaria (NTDs/malaria); and other infectious diseases. Deaths, age-standardized mortality rates, and age-specific mortality rates were analysed for BRICS countries from 1990 to 2023. Temporal trends were quantified using the estimated annual percentage change. Results: Infectious-disease deaths in BRICS declined from 5.014 million in 1990 to 2.574 million in 2023, and the BRICS share of global infectious-disease deaths decreased from 40% to 31%. Patterns differed by disease and country. HIV/AIDS and sexually transmitted infection deaths increased by 564.65%, with adverse age-standardized trends in South Africa, Russia, China, and India. Respiratory infections and tuberculosis increased in Brazil, Russia, and South Africa, whereas China and India maintained long-term declines. Enteric infections decreased in all five countries. Except for HIV/AIDS and sexually transmitted infections, mortality became increasingly concentrated at older ages by 2023. Conclusion: BRICS achieved major reductions in infectious-disease mortality, but progress was uneven. Post-pandemic control should prioritize HIV-related mortality, respiratory infection and tuberculosis recovery, and age-sensitive prevention.